Table 3.
Variable | Supplementation | Rest | Stage 1 | Stage 2 | Stage 3 |
---|---|---|---|---|---|
SBP | Placebo | 116 ± 8 | 125 ± 2 | 126 ± 4 | 134 ± 8 |
Nitrate | 112 ± 6 | 124 ± 6 | 123 ± 7 | 136 ± 8 | |
DBP | Placebo | 74 ± 6 | 78 ± 8 | 78 ± 4 | 81 ± 5 |
Nitrate | 72 ± 7 | 67 ±5 † | 73 ± 4 ‡ | 71 ± 5 † | |
MAP | Placebo | 88 ± 5 | 93 ± 6 | 94 ± 3 | 99 ± 4 |
- | Nitrate | 85 ± 6 | 86 ± 4 † | 89 ± 5 ‡ | 93 ± 6 † |
No differences were noted between interventions for SBP at rest or any of the exercise stages. The difference in DBP between interventions during stage two and three had large and medium ES, respectively. There were medium to large ES for the differences between interventions in MAP and RPP at all stages of exercise. All data is presented as mean ± SEM. Cohen’s D effect sizes of the difference between interventions are indicated as follows: medium (>0.5) effect size-†, large (>0.8) effect size-‡. Abbreviations: SBP, systolic blood pressure, DBP, diastolic blood pressure, MAP, mean arterial blood pressure.